Status:
UNKNOWN
Tight End-tidal Gas Control During Anesthesia to Decrease Postoperative Delirium Anesthetic Management
Lead Sponsor:
University of Manitoba
Conditions:
Post-Operative Confusion
Delirium
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Respiratory end-tidal gas control is a fundamental of anesthetic management. The range of end-tidal (ET) O2 and CO2 during the conduct of anesthesia is far outside that found in the awake state. Recen...
Detailed Description
A. Background and Rationale: Although respiratory end-tidal gas control is a fundamental principle of anesthetic management, the range of end-tidal (ET) O2 and CO2 typically seen during the conduct o...
Eligibility Criteria
Inclusion
- able to provide informed consent
- elective major surgery requiring a minimum stay of 2 days postoperatively
- no contraindication to MRI
Exclusion
- unable to provide informed consent
- CO2 retention with Chronic Obstructive Pulmonary Disease (COPD)
- active congestive heart failure (CHF)
- unable to participate adequately in delirium screening including those who are blind, deaf, illiterate or not fluent English or French
- prior episode of intraoperative awareness
Key Trial Info
Start Date :
June 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04406350
Start Date
June 15 2020
End Date
December 31 2021
Last Update
May 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Sciences Centre
Winnipeg, Manitoba, Canada, R3A 1R9